Neuro-ophthalmological emergencies constitute vision or life-threatening conditions if diagnosis and treatment are not promptly undertaken. Even with immediate therapy, these clinical entities carry a high rate of morbidity. They may present with diplopia, visual loss, and/or anisocoria. Arteritic anterior ischemic optic neuropathy is an ominous condition, which can cause permanent and severe vision loss, stroke, or aortic dissection, requiring immediate steroid therapy. Pituitary apoplexy may go unnoticed if only computed axial tomography is performed. Diseases affecting the cavernous sinus and orbital apex region, such as cavernous sinus thrombosis or mucormycosis, can give rise to simultaneous vision loss and diplopia and, if not treated, may extend to the brain parenchyma causing permanent neurological sequela. An isolated third nerve palsy may be the harbinger of a cerebral aneurysm, carrying a significant risk of mortality. Horner syndrome can be the initial presentation of a carotid dissection, an important cause of stroke in the young adult. The neurohospitalist should be familiar with the workup and management of neuro-ophthalmological emergencies.
TrobeJ. The Neurology of Vision. Contemporary Neurology Series. Oxford, United Kingdom: Oxford University Press; 2001.
3.
FineAMElmanMJEbertJEPrestiaPAStarrJSFineSL. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol. 1986;104(4):513–514.
4.
GlaserJSSavinoPJSumersKDMcDonaldSAKnightonRW. The photostress recovery test in the clinical assessment of visual function. Am J Ophthalmol. 1977;83(2):255–260.
5.
JohnsonLNArnoldAC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994;14(1):38–44.
6.
HayrehSSPodhajskyPAZimmermanB. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509–20.
7.
WeyandCMGoronzyJJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003;349(2):160–169.
8.
LiozonEHerrmannFLyK. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001;111(3):211–217.
SmetanaGWShmerlingRH. Does this patient have temporal arteritis?JAMA. 2002;287(1):92–101.
11.
HayrehSSPodhajskyPARamanRZimmermanB. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123(3):285–296.
12.
SiatkowskiRMGassJDGlaserJSSmithJLSchatzNJSchiffmanJ. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol. 1993;115(1):57–63.
13.
ParikhMMillerNRLeeAG. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113(10):1842–1845.
14.
CostelloFZimmermanMBPodhajskyPAHayrehSS. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol. 2004;14(3):245–257.
15.
KermaniTASchmidtJCrowsonCS. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41(6):866–871.
16.
ForoozanRDanesh-MeyerHSavinoPJGambleGMekari-SabbaghONSergottRC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2002;109(7):1267–1271.
17.
CoppetoJRMonteiroM. Diagnosis of highly occult giant cell arteritis by repeat temporal artery biopsies. Some observations. Neuro-Ophthalmology. 1990;10(4):217–218.
HallJKVolpeNJGalettaSLLiuGTSyedNABalcerLJ. The role of unilateral temporal artery biopsy. Ophthalmology. 2003;110(3):543–548; discussion 8.
20.
Danesh-MeyerHVSavinoPJEagleRCJrKubisKCSergottRC. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20(3):213–215.
21.
BallELWalshSRTangTYGohilRClarkeJM. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg. 2010;97(12):1765–1771.
22.
BleyTAUhlMCarewJ. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28(9):1722–1727.
23.
FontCCidMCColl-VinentBLopez-SotoAGrauJM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol. 1997;36(2):251–254.
24.
HayrehSSBiousseV. Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids?J Neuroophthalmol. 2012;32(3):278–287.
25.
HayrehSSZimmermanB. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217(4):239–259.
26.
HoffmanGSCidMCHellmannDB. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46(5):1309–1318.
27.
HayrehSSZimmermanB. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–1215.
28.
HoffmanGSCidMCRendt-ZagarKE. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146(9):621–630.
29.
SerorRBaronGHachullaE. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial. Ann Rheum Dis. 2014;73(12):2074–2081.
30.
NesherGBerkunYMatesMBarasMRubinowASonnenblickM. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50(4):1332–1337.
NawarRNAbdelMannanDSelmanWRArafahBM. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008;23(2):75–90.
34.
BillsDCMeyerFBLawsERJr. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33(4):602–608; discussion 8-9.
35.
MaccagnanPMacedoCLKayathMJNogueiraRGAbuchamJ. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995;80(7):2190–2197.
36.
JoshiNCaputoGMWeitekampMRKarchmerAW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–1912.
37.
YohaiRABullockJDAzizAAMarkertRJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39(1):3–22.
38.
BinderUMaurerELass-FlorlC. Mucormycosis—from the pathogens to the disease. Clin Microbiol Infect. 2014;20(suppl 6):60–66.
39.
RodenMMZaoutisTEBuchananWL. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653.
40.
ReesJRPinnerRWHajjehRABrandtMEReingoldAL. The epidemiological features of invasive mycotic infections in the San Francisco Bay Area, 1992–1993: results of Population-Based Laboratory Active Surveillance. Clin Infect Dis. 1998;27(5):1138–1147.
41.
DiwakarADewanRKChowdharyARandhawaHSKhannaGGaurSN. Zygomycosis—a case report and overview of the disease in India. Mycoses. 2007;50(4):247–254.
42.
ThurtellMJChiuALGooldLA. Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clin Experiment Ophthalmol. 2013;41(6):567–576.
43.
FerryAPAbediS. Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases. Ophthalmology. 1983;90(9):1096–1104.
PrabhuRMPatelR. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(suppl 1):31–47.
LevineSRTwymanREGilmanS. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988;38(4):517–522.
60.
CoutinhoJMFerroJMCanhaoPBarinagarrementeriaFBousserMGStamJ. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41(11):2575–2580.
61.
CanhaoPCortesaoACabralM. Are steroids useful to treat cerebral venous thrombosis?Stroke. 2008;39(1):105–110.
62.
KeaneJR. Third nerve palsy: analysis of 1400 personally-examined inpatients. Can J Neurol Sci. 2010;37(5):662–670.
63.
LaereEV. Non-traumatic paralysis of the oculomotor nerve. A review of 109 cases (author’s transl) [in French]. Acta Neurol Belg. 1974;74(3):182–192.
64.
BerlitP. Isolated and combined pareses of cranial nerves III, IV and VI. A retrospective study of 412 patients. J Neurol Sci. 1991;103(1):10–15.
65.
HamiltonJGFalconerMA. Immediate and late results of surgery in cases of saccular intracranial aneurysms. J Neurosurg. 1959;16:514–541.
66.
SoniSR. Aneurysms of the posterior communicating artery and oculomotor paresis. J Neurol Neurosurg Psychiatry. 1974;37(4):475–484.
67.
WinnHRJaneJASrTaylorJKaiserDBritzGW. Prevalence of asymptomatic incidental aneurysms: review of 4568 arteriograms. J Neurosurg. 2002;96(1):43–49.
68.
MenghiniVVBrownRDJrSicksJDO’FallonWMWiebersDO. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota, 1965 to 1995. Neurology. 1998;51(2):405–411.
69.
WardlawJMWhitePM. The detection and management of unruptured intracranial aneurysms. Brain. 2000;123(pt 2):205–221.
70.
WiebersDOWhisnantJPHustonJIII. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103–110.
71.
BirchallDKhangureMSMcAuliffeW. Resolution of third nerve paresis after endovascular management of aneurysms of the posterior communicating artery. AJNR Am J Neuroradiol. 1999;20(3):411–413.
72.
GiombiniSFerraresiSPluchinoF. Reversal of oculomotor disorders after intracranial aneurysm surgery. Acta Neurochir (Wien). 1991;112(1-2):19–24.
73.
HylandHHBarnettHJ. The pathogenesis of cranial nerve palsies associated with intracranial aneurysms. Proc R Soc Med. 1954;47(2):141–146.
74.
KisselJTBurdeRMKlingeleTGZeigerHE. Pupil-sparing oculomotor palsies with internal carotid-posterior communicating artery aneurysms. Ann Neurol. 1983;13(2):149–154.
75.
TrobeJD. Third nerve palsy and the pupil. Footnotes to the rule. Arch Ophthalmol. 1988;106(5):601–602.
76.
TrobeJD. Isolated pupil-sparing third nerve palsy. Ophthalmology. 1985;92(1):58–61.
77.
CapoHWarrenFKupersmithMJ. Evolution of oculomotor nerve palsies. J Clin Neuroophthalmol. 1992;12(1):21–25.
78.
LeeAGHaymanLABrazisPW. The evaluation of isolated third nerve palsy revisited: an update on the evolving role of magnetic resonance, computed tomography, and catheter angiography. Surv Ophthalmol. 2002;47(2):137–157.
79.
JacobsonDM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol. 1998;116(6):723–727.
80.
VaphiadesMSCureJKlineL. Management of intracranial aneurysm causing a third cranial nerve palsy: MRA, CTA or DSA?Semin Ophthalmol. 2008;23(3):143–150.
81.
GuDQLuoBZhangXLongXADuanCZ. Recovery of posterior communicating artery aneurysm-induced oculomotor nerve paresis after endovascular treatment. Clin Neurol Neurosurg. 2012;114(9):1238–1242.
82.
WilhelmHChristopherKLeighRJ. Disorders of the pupil. Neuro-Ophthalmology: Handbook of Clinical Neurology, Vol 102 (Series Editors: Aminoff, Boller and Swaab). Amsterdam, the Netherlands: Elsevier; 2011:427–466.
83.
FisherCMOjemannRGRobersonGH. Spontaneous dissection of cervico-cerebral arteries. Can J Neurol Sci. 1978;5(1):9–19.
84.
PutaalaJMetsoAJMetsoTM. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195–1203.
85.
GiroudMFayolleHAndreN. Incidence of internal carotid artery dissection in the community of Dijon. J Neurol Neurosurg Psychiatry. 1994;57(11):1443.
86.
ArnoldMKappelerLGeorgiadisD. Gender differences in spontaneous cervical artery dissection. Neurology. 2006;67(6):1050–1052.
87.
DziewasRKonradCDragerB. Cervical artery dissection—clinical features, risk factors, therapy and outcome in 126 patients. J Neurol. 2003;250(10):1179–1184.
88.
SilbertPLMokriBSchievinkWI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology. 1995;45(8):1517–1522.
89.
ArnoldMCumurciucRStapfCFavrolePBerthetKBousserMG. Pain as the only symptom of cervical artery dissection. J Neurol Neurosurg Psychiatry. 2006;77(9):1021–1024.
90.
BiousseVTouboulPJD’Anglejan-ChatillonJLevyCSchaisonMBousserMG. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol. 1998;126(4):565–577.
91.
SchneiderUHermannAErnemannUBartz-SchmidtKU. Central retinal artery occlusion secondary to spontaneous internal carotid artery dissection. Retina. 2004;24(6):979–981.
92.
DukerJSBelmontJB. Ocular ischemic syndrome secondary to carotid artery dissection. Am J Ophthalmol. 1988;106(6):750–752.
93.
MokriBSilbertPLSchievinkWIPiepgrasDG. Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology. 1996;46(2):356–359.
94.
MehiganJTOlcottCt. The carotid “string” sign. Differential diagnosis and management. Am J Surg. 1980;140(1):137–1343.
95.
LevyCLaissyJPRaveauV. Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography. Radiology. 1994;190(1):97–103.
96.
ProvenzaleJMSarikayaB. Comparison of test performance characteristics of MRI, MR angiography, and CT angiography in the diagnosis of carotid and vertebral artery dissection: a review of the medical literature. AJR Am J Roentgenol. 2009;193(4):1167–1174.
97.
BenningerDHCasoVBaumgartnerRW. Ultrasound assessment of cervical artery dissection. Front Neurol Neurosci. 2005;20:87–101.
98.
MenonRKerrySNorrisJWMarkusHS. Treatment of cervical artery dissection: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2008;79(10):1122–1127.
99.
RothrockJFLimVPressGGosinkB. Serial magnetic resonance and carotid duplex examinations in the management of carotid dissection. Neurology. 1989;39(5):686–692.
100.
BenningerDHGeorgiadisDKremerCStuderANedeltchevKBaumgartnerRW. Mechanism of ischemic infarct in spontaneous carotid dissection. Stroke. 2004;35(2):482–485.
101.
KennedyFLanfranconiSHicksC. Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis. Neurology. 2012;79(7):686–689.
102.
LeeVHBrownRDJrMandrekarJNMokriB. Incidence and outcome of cervical artery dissection: a population-based study. Neurology. 2006;67(10):1809–1812.
103.
BassiPLattuadaPGomitoniA. Cervical cerebral artery dissection: a multicenter prospective study (preliminary report). Neurol Sci. 2003;24(suppl 1):S4–S7.
104.
PelkonenOTikkakoskiTLeinonenSPyhtinenJLepojarviMSotaniemiK. Extracranial internal carotid and vertebral artery dissections: angiographic spectrum, course and prognosis. Neuroradiology. 2003;45(2):71–77.
105.
GeorgiadisDArnoldMvon BuedingenHC. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology. 2009;72(21):1810–1815.
106.
KremerCMossoMGeorgiadisD. Carotid dissection with permanent and transient occlusion or severe stenosis: long-term outcome. Neurology. 2003;60(2):271–275.
